# Pappalysin 2 (PAPP-A2) Enzyme Replacement

> **NCT02412943** · PHASE1 · COMPLETED · sponsor: **Children's Hospital Medical Center, Cincinnati** · enrollment: 1 (actual)

## Conditions studied

- Short Stature, Idiopathic

## Interventions

- **OTHER:** Fresh Frozen Plasma

## Key facts

- **NCT ID:** NCT02412943
- **Lead sponsor:** Children's Hospital Medical Center, Cincinnati
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-04
- **Primary completion:** 2015-05
- **Final completion:** 2015-05
- **Target enrollment:** 1 (ACTUAL)
- **Last updated:** 2015-05-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02412943

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02412943, "Pappalysin 2 (PAPP-A2) Enzyme Replacement". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02412943. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*